JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2003; 41:870-878, doi:10.1016/S0735-1097(02)02935-2
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamanaka, S.
Right arrow Articles by Nakagawa, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamanaka, S.
Right arrow Articles by Nakagawa, M.

EXPERIMENTAL STUDY

Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytes

Satoshi Yamanaka, MD*, Tetsuya Tatsumi, MD, PhD*,*, Jun Shiraishi, MD*, Akiko Mano, MD*, Natsuya Keira, MD*, Satoaki Matoba, MD, PhD*, Jun Asayama, MD, PhD{ddagger}, Shinji Fushiki, MD, PhD{dagger}, Henry Fliss, PhD§ and Masao Nakagawa, MD, PhD*

* Second Department of Medicine, Kyoto, Japan
{dagger} Department of Dynamic Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan
{ddagger} Department of Clinical Pharmacology, Kyoto Pharmaceutical University, Kyoto, Japan
§ Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada

Manuscript received December 3, 2001; revised manuscript received July 17, 2002, accepted October 17, 2002.

* Reprint requests and correspondence: Dr. Tetsuya Tatsumi, Second Department of Medicine, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.
tatsumi{at}koto.kpu-m.ac.jp

OBJECTIVES: We examined whether amlodipine, a calcium channel antagonist with potent antioxidant activity, inhibits doxorubicin-induced apoptosis in cultured neonatal rat cardiac myocytes.

BACKGROUND: Recent studies have shown that doxorubicin induces apoptosis as well as necrosis in myocytes through generation of reactive oxygen species.

METHODS: The effects of amlodipine and several other antioxidants on doxorubicin-induced oxidative stress and mitochondria-mediated apoptosis were examined.

RESULTS: Treatment of myocytes with doxorubicin (10–6 mol/l) for 14 h increased the number of cells with elevated peroxides, as histochemically estimated by 2',7'-dichlorofluorescin (DCF) diacetate, and the percentage of apoptotic myocytes, as estimated by Hoechst 33258 nuclear staining, compared with control myocytes (25.0 ± 1.6% vs. 5.2 ± 1.2%). Moreover, doxorubicin-induced myocyte apoptosis was also confirmed by annexin V–fluorescein isothiocyanate binding assay. Doxorubicin induced a reduction in myocyte adenosine 5'-triphosphate content, a loss of mitochondrial membrane potential, cytochrome c release from the mitochondria into the cytosol, and caspase-3 activation to 1.9-fold of control. Amlodipine significantly attenuated increased DCF fluorescence, inhibited the mitochondria-mediated apoptotic responses described earlier, and decreased apoptosis in the doxorubicin-treated myocytes in a dose-dependent fashion. Amlodipine at 10–6 mol/l significantly decreased apoptosis to 15.4 ± 0.7%, and this antiapoptotic action was more effective than that seen with other antioxidants, including probucol, ascorbic acid, and alpha-tocopherol. In contrast, the calcium channel antagonist nifedipine (10–6 mol/l) did not inhibit apoptosis. Catalase, glutathione, and N-acetylcysteine, but not mannitol or superoxide dismutase, significantly decreased DCF fluorescence and attenuated myocyte apoptosis induced by doxorubicin to 18.7 ± 1.2%, 19.1 ± 1.7%, and 18.7 ± 0.6%, respectively.

CONCLUSIONS: Amlodipine significantly inhibits doxorubicin-induced myocyte apoptosis by suppressing the mitochondrial apoptotic pathway. This effect is attributed to the antioxidant properties of amlodipine, affecting mainly hydrogen peroxide.

Abbreviations and Acronyms
  ATP
  adenosine 5'-triphosphate
  Bax
  Bcl-2–associated X protein
  DCF
  2',7'-dichlorofluorescein
  DMEM
  Dulbecco’s modified Eagle’s medium
  FITC
  fluorescein isothiocyanate
  H2DCFDA
  2',7'-dichlorofluorescin diacetate
  JC-1
  5,5',6,6'-tetrachloro-1,1',3'tetraethylbenzimidazolylcarbocyanine iodide
  MAPK
  mitogen-activated protein kinase
  NAC
  N-acetylcysteine
  PBS
  phosphate-buffered saline
  SOD
  superoxide dismutase




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
G. Li, Y. Xiao, and L. Zhang
Cocaine Induces Apoptosis in Fetal Rat Myocardial Cells through the p38 Mitogen-Activated Protein Kinase and Mitochondrial/Cytochrome c Pathways
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 112 - 119.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
E. KEYHANI and J. KEYHANI
Plasma Membrane Alteration Is an Early Signaling Event in Doxorubicin-Induced Apoptosis in the Yeast Candida utilis
Ann. N.Y. Acad. Sci., December 1, 2004; 1030(1): 369 - 376.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Mano, T. Tatsumi, J. Shiraishi, N. Keira, T. Nomura, M. Takeda, S. Nishikawa, S. Yamanaka, S. Matoba, M. Kobara, et al.
Aldosterone Directly Induces Myocyte Apoptosis Through Calcineurin-Dependent Pathways
Circulation, July 20, 2004; 110(3): 317 - 323.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. L'Ecuyer, Z. Allebban, R. Thomas, and R. Vander Heide
Glutathione S-transferase overexpression protects against anthracycline-induced H9C2 cell death
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2057 - H2064.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2003 by the American College of Cardiology Foundation.